clinical trial · NCT05986786
Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
Alvotech Swiss AG·phase3·completed·n = 35
Chorioretinal Vascular DiseasePatients will receive 1 IVT injection of AVT06 PFS depending on their chorioretinal vascular disease schedule
brief summary
This is a single-arm, open label, multicenter clinical study to evaluate the handling and safety of AVT06 pre-filled syringe (PFS) in subjects with chorioretinal vascular disease followed by an optional extension phase of AVT06 pre-filled syringe (PFS)
started
Feb 28, 2024
primary completion
Apr 19, 2024
completion
Mar 21, 2025
last updated
Apr 22, 2025
official title
Single-arm, Open Label, Multicenter Clinical Study to Evaluate the Handling and Safety of AVT06 Pre-filled Syringe (PFS) in Subjects With Chorioretinal Vascular Disease Followed by an Optional Extension Phase of AVT06 Pre-filled Syringe (PFS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol